| Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects S Kunjachan, J Ehling, G Storm, F Kiessling, T Lammers Chemical reviews 115 (19), 10907-10937, 2015 | 497 | 2015 |
| Passive versus Active Tumor Targeting Using RGD-and NGR-Modified Polymeric Nanomedicines S Kunjachan, R Pola, F Gremse, B Theek, J Ehling, D Moeckel, ... Nano letters 14 (2), 972-981, 2014 | 372 | 2014 |
| CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis J Ehling, M Bartneck, X Wei, F Gremse, V Fech, D Möckel, C Baeck, ... Gut 63 (12), 1960-1971, 2014 | 322 | 2014 |
| Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles Y Shi, R van der Meel, B Theek, E Oude Blenke, EHE Pieters, ... ACS nano 9 (4), 3740-3752, 2015 | 215 | 2015 |
| Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging Z Liu, T Lammers, J Ehling, S Fokong, J Bornemann, F Kiessling, ... Biomaterials 32 (26), 6155-6163, 2011 | 181 | 2011 |
| Peptide-functionalized gold nanorods increase liver injury in hepatitis M Bartneck, T Ritz, HA Keul, M Wambach, J Bornemann, U Gbureck, ... ACS nano 6 (10), 8767-8777, 2012 | 176 | 2012 |
| Micro-CT Imaging of Tumor Angiogenesis: Quantitative Measures Describing Micromorphology and Vascularization J Ehling, B Theek, F Gremse, S Baetke, D Möckel, J Maynard, SA Ricketts, ... The American journal of pathology 184 (2), 431-441, 2014 | 172 | 2014 |
| Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation T Lammers, P Koczera, S Fokong, F Gremse, J Ehling, M Vogt, A Pich, ... Advanced Functional Materials 25 (1), 36-43, 2015 | 163 | 2015 |
| Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction EA Liehn, N Tuchscheerer, I Kanzler, M Drechsler, L Fraemohs, A Schuh, ... Journal of the American College of Cardiology 58 (23), 2415-2423, 2011 | 161 | 2011 |
| Quantitative micro-computed tomography imaging of vascular dysfunction in progressive kidney diseases J Ehling, J Bábíčková, F Gremse, BM Klinkhammer, S Baetke, R Knuechel, ... Journal of the American Society of Nephrology: JASN 27 (2), 520, 2016 | 152 | 2016 |
| Fibrosis imaging: Current concepts and future directions M Baues, A Dasgupta, J Ehling, J Prakash, P Boor, F Tacke, F Kiessling, ... Advanced drug delivery reviews 121, 9-26, 2017 | 142 | 2017 |
| MO025NON-INVASIVE MOLECULAR IMAGING OF KIDNEY FIBROSIS J Ehling, BM Klinkhammer, Q Sun, M Baues, F Kiessling, J Floege, ... Nephrology Dialysis Transplantation 31 (suppl 1), i38-i38, 2016 | 136* | 2016 |
| Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging B Theek, F Gremse, S Kunjachan, S Fokong, R Pola, M Pechar, ... Journal of Controlled Release 182, 83-89, 2014 | 131 | 2014 |
| Imalytics Preclinical: Interactive Analysis of Biomedical Volume Data F Gremse, M Stärk, J Ehling, JR Menzel, T Lammers, F Kiessling Theranostics 6 (3), 328, 2016 | 116 | 2016 |
| Iron Oxide‐Labeled Collagen Scaffolds for Non‐Invasive MR Imaging in Tissue Engineering ME Mertens, A Hermann, A Bühren, L Olde‐Damink, D Möckel, F Gremse, ... Advanced functional materials 24 (6), 754-762, 2014 | 114 | 2014 |
| Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease M Bartneck, V Fech, J Ehling, O Govaere, KT Warzecha, K Hittatiya, ... Hepatology 63 (4), 1310-1324, 2016 | 105 | 2016 |
| The theranostic path to personalized nanomedicine B Theek, LY Rizzo, J Ehling, F Kiessling, T Lammers Clinical and Translational Imaging 2 (1), 67-76, 2014 | 96 | 2014 |
| Non-invasive imaging for studying anti-angiogenic therapy effects J Ehling, T Lammers, F Kiessling Thromb Haemost 109 (3), 375-390, 2013 | 92 | 2013 |
| The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance J Gautheron, M Vucur, AT Schneider, I Severi, C Roderburg, S Roy, ... Nature communications 7 (1), 1-16, 2016 | 88 | 2016 |
| Role of chemokine pathways in hepatobiliary cancer J Ehling, F Tacke Cancer letters 379 (2), 173-183, 2016 | 86 | 2016 |